Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL

Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).

• Catégorie